Seminar of Inst. NanoEngineering and MicroSystems, May 6, 2019

奈米工程與微系統研究所 書報討論

Seminar of Inst. NanoEngineering and MicroSystems

Speech I. Chung-hsiun Wu

CEO,

Development Center for Biotechnology(TW) 

Title:  Nanotechnologies in Precision Medicine.

Abstract

Development Center for Biotechnology is a non-profit research organization focusing on the promotion of biotechnology industry. Through the years, we have established technology platforms for the development of small molecule drugs and biologics, especially therapeutic monoclonal antibodies. In this brief introduction, we’ll disclose capabilities in the pre-clinical and clinical development of innovative medicines and discuss different models of collaboration. In the second part of the discussion, we’ll go through several cutting edge technologies for the future medicine, including artificial intelligence, cell therapy, microbiome, nanotechnologies, and precision medicine.

Brief Biography

B.S., National Taiwan University, Department of Plant Pathology and Microbiology, Taipei, Taiwan.

Ph.D., University of Maryland, Department of Biochemistry, USA.

生物技術開發中心副執行長(Deputy CEO)

生物技術開發中心生物製藥研究所所長

金思維生物科技負責人(Principal)

台醫生物科技共同創辦人(Co-founder)暨研發長及業務副總

NTU College Of Medicine分子醫學研究所(Inst. Of Molecular Medicine)專任副教授(Professor)

Carnegie Institution of Washington Department of Embryology

Jane-Coffin-Childs Memorial Fund Fellow

15:30-17:20 on May 6th(Mon), 2019 at Room 108 of Eng. Building I

Host:Prof. J.Andrew Yeh jayeh@mx.nthu.edu.tw Ext:42912

Contact:Yu-Chen